Kenneth J. Bloom, MD has been Medical Director since August 2004 and Chief Medical Officer since 2005. Dr. Bloom came to Clarient from Irvine, CA-based US Labs, where he served as Senior Medical Director since 2002. Prior to that, Dr. Bloom spent more than two decades serving in senior academic, consultative and clinical roles with leading hospitals and healthcare enterprises principally in the specialization of cancer care.
Dr. Bloom’s academic posts have included over 10 years as Associate Professor of Pathology at Chicago-based Rush Medical College, as well as one year as a visiting Professor in the Department of Computer Science at DePaul University. Over the past 15 years, Dr. Bloom has held more than 10 appointed positions at Chicago-based Rush Presbyterian - St. Luke’s Medical Center, one of the leading cancer research hospitals in the US. Those positions included Director of Laboratory Operations, Director of Immunohistochemistry, and Director of the Breast Service in the Department of Pathology, Consultant to the Rush Breast Cancer Center, and Director of Information Services for the Rush Cancer Institute.
Dr. Bloom has, for more than three decades, been a prolific researcher and lecturer in the fields of pathology and, specifically, cancer related topics. During his tenure at Rush, his published studies validating the benefits of ACIS® (Automated Cellular Imaging System) image analysis for HER2 evaluation were instrumental in gaining broad acceptance for the Clarient technology. He has been a member of the College of American Pathologists since 1987 and currently serves as a member of the Immunohistochemistry and Technology Assessment Committees for that organization.
In addition to US LABS and the other roles mentioned above, Dr. Bloom has served the industry off and on for the past 20 years in both advisory and operational roles. Those appointments include Board of Directors seats, consulting roles and executive posts including executive level positions at both diagnostics technology and information technology firms.
|